A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma

A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma

Background: Diffuse large B-cell lymphoma (DLBCL) is a genetically heterogeneous disease that can have profound differences in survival outcomes. A variety of powerful prognostic factors and models have been constructed; however, the development of more accurate prognosis prediction and targeted tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong Xu, Yuhang Li, Yanan Jiang, Jinhuan Wang, Huimeng Sun, Wenqi Wu, Yangyang LV, Su Liu, Yixin Zhai, LinYan Tian, Lanfang Li, Zhigang Zhao
Formato: Artículo
Lenguaje:English
Publicado: Frontiers Media S.A. 2022-06-01
Colección:Frontiers in Genetics
Materias:
super-enhancer
LASSO
diffuse large B-cell lymphoma
prognostic model
overall survival
Acceso en línea:https://www.frontiersin.org/articles/10.3389/fgene.2022.827840/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2022.827840/full

Ejemplares similares